{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:31:27Z","timestamp":1793039487614,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.xphs.2019.07.004","type":"journal-article","created":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T19:33:27Z","timestamp":1563910407000},"page":"3599-3608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["A Self-Nanoemulsifying Drug Delivery System for Enhancing the Oral Bioavailability of Candesartan Cilexetil: Ex\u00a0Vivo and In\u00a0Vivo Evaluation"],"prefix":"10.1016","volume":"108","author":[{"given":"Khaled","family":"AboulFotouh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayat A.","family":"Allam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"El-Badry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.xphs.2019.07.004_bib1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2010.10.013","article-title":"Nanoemulsion improves the oral absorption of candesartan cilexetil in rats: performance and mechanism","volume":"149","author":"Gao","year":"2011","journal-title":"J\u00a0Control Release"},{"issue":"5","key":"10.1016\/j.xphs.2019.07.004_bib2","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.nano.2011.08.016","article-title":"Solid lipid nanoparticles loading candesartan cilexetil enhance oral bioavailability: in\u00a0vitro characteristics and absorption mechanism in rats","volume":"8","author":"Zhang","year":"2012","journal-title":"Nanomedicine"},{"issue":"87","key":"10.1016\/j.xphs.2019.07.004_bib3","doi-asserted-by":"crossref","first-page":"71500","DOI":"10.1039\/C5RA11687B","article-title":"Systematic development of novel cationic self-nanoemulsifying drug delivery systems of candesartan cilexetil with enhanced biopharmaceutical performance","volume":"5","author":"Sharma","year":"2015","journal-title":"RSC Adv"},{"issue":"3","key":"10.1016\/j.xphs.2019.07.004_bib4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jsps.2013.03.006","article-title":"Enhanced solubility and intestinal absorption of candesartan cilexetil solid dispersions using everted rat intestinal sacs","volume":"22","author":"Gurunath","year":"2014","journal-title":"Saudi Pharm J"},{"issue":"2-3","key":"10.1016\/j.xphs.2019.07.004_bib5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/bdd.699","article-title":"Interaction of angiotensin receptor type 1 blockers with ATP-binding cassette transporters","volume":"31","author":"Weiss","year":"2010","journal-title":"Biopharm Drug Dispos"},{"issue":"1","key":"10.1016\/j.xphs.2019.07.004_bib6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.lfs.2009.11.006","article-title":"Interaction of angiotensin II type 1 receptor blockers with P-gp substrates in Caco-2 cells and hMDR1-expressing membranes","volume":"86","author":"Kamiyama","year":"2010","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.xphs.2019.07.004_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0169-409X(96)00490-5","article-title":"Formulation of self-emulsifying drug delivery systems","volume":"25","author":"Pouton","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2019.07.004_bib8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.colsurfb.2013.08.025","article-title":"Self nanoemulsifying drug delivery system (SNEDDS) of Rosuvastatin calcium: design, formulation, bioavailability and pharmacokinetic evaluation","volume":"112","author":"Balakumar","year":"2013","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.xphs.2019.07.004_bib9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.colsurfb.2018.03.034","article-title":"Role of self-emulsifying drug delivery systems in optimizing the oral delivery of hydrophilic macromolecules and reducing interindividual variability","volume":"167","author":"AboulFotouh","year":"2018","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"14","key":"10.1016\/j.xphs.2019.07.004_bib10","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2217\/nnm-2017-0354","article-title":"Self-emulsifying drug\u2013delivery systems modulate P-glycoprotein activity: role of excipients and formulation aspects","volume":"13","author":"AboulFotouh","year":"2018","journal-title":"Nanomedicine"},{"issue":"6","key":"10.1016\/j.xphs.2019.07.004_bib11","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.addr.2007.10.010","article-title":"Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies","volume":"60","author":"Pouton","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.xphs.2019.07.004_bib12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2009.10.005","article-title":"Impact of emulsion-based drug delivery systems on intestinal permeability and drug release kinetics","volume":"142","author":"Buyukozturk","year":"2010","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.xphs.2019.07.004_bib13","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ejps.2017.09.001","article-title":"Development and in vitro\/in\u00a0vivo performance of self-nanoemulsifying drug delivery systems loaded with candesartan cilexetil","volume":"109","author":"AboulFotouh","year":"2017","journal-title":"Eur J Pharm Sci"},{"issue":"15","key":"10.1016\/j.xphs.2019.07.004_bib14","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1081\/JLC-120023802","article-title":"Simultaneous analysis of candesartan cilexetil and hydrochlorothiazide in human plasma and dosage forms using HPLC with a photodiode array detector","volume":"26","author":"Erk","year":"2003","journal-title":"J\u00a0Liq Chromatogr Relat Technol"},{"issue":"4","key":"10.1016\/j.xphs.2019.07.004_bib15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1517\/13543776.2011.561784","article-title":"The emerging role of P-glycoprotein inhibitors in drug delivery: a patent review","volume":"21","author":"Akhtar","year":"2011","journal-title":"Expert Opin Ther Pat"},{"issue":"4","key":"10.1016\/j.xphs.2019.07.004_bib16","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ejps.2008.12.005","article-title":"Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats","volume":"36","author":"Bansal","year":"2009","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2019.07.004_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijpharm.2010.10.017","article-title":"Excipients enhance intestinal absorption of ganciclovir by P-gp inhibition: assessed in\u00a0vitro by everted gut sac and in situ by improved intestinal perfusion","volume":"403","author":"Li","year":"2011","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2019.07.004_bib18","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.2042-7158.2011.01391.x","article-title":"Everted gut sac model as a tool in pharmaceutical research: limitations and applications","volume":"64","author":"Alam","year":"2012","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.xphs.2019.07.004_bib19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejps.2016.12.014","article-title":"Development of novel self-assembled ES-PLGA hybrid nanoparticles for improving oral absorption of doxorubicin hydrochloride by P-gp inhibition: in\u00a0vitro and in\u00a0vivo evaluation","volume":"99","author":"Wang","year":"2017","journal-title":"Eur J Pharm Sci"},{"issue":"7","key":"10.1016\/j.xphs.2019.07.004_bib20","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1021\/acs.molpharmaceut.5b00010","article-title":"Multifunctional poly(methyl vinyl ether-co-maleic anhydride)-graft-hydroxypropyl-\u03b2-cyclodextrin amphiphilic copolymer as an oral high-performance delivery carrier of tacrolimus","volume":"12","author":"Zhang","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2019.07.004_bib21","first-page":"4099","article-title":"Enhanced absorption of hydroxysafflor yellow A using a self-double-emulsifying drug delivery system: in\u00a0vitro and in\u00a0vivo studies","volume":"7","author":"Lv","year":"2012","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.xphs.2019.07.004_bib22","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.colsurfb.2017.11.064","article-title":"Nanostructured lipid carriers for improved oral delivery and prolonged antihyperlipidemic effect of simvastatin","volume":"162","author":"Fathi","year":"2018","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"1","key":"10.1016\/j.xphs.2019.07.004_bib23","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jchromb.2005.09.015","article-title":"Biocompatible in-tube solid-phase microextraction coupled to HPLC for the determination of angiotensin II receptor antagonists in human plasma and urine","volume":"828","author":"Nie","year":"2005","journal-title":"J\u00a0Chromatogr B"},{"key":"10.1016\/j.xphs.2019.07.004_bib24","series-title":"Nanotechnology for Nucleic Acid Delivery: Methods and Protocols","first-page":"13","article-title":"Lactate dehydrogenase assay for assessment of polycation cytotoxicity","author":"Parhamifar","year":"2013"},{"issue":"1","key":"10.1016\/j.xphs.2019.07.004_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0378-5173(02)00343-5","article-title":"Influence of monocaprin on the permeability of a diacidic drug BTA-243 across Caco-2 cell monolayers and everted gut sacs","volume":"245","author":"Brown","year":"2002","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2019.07.004_bib26","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1023\/A:1016100715125","article-title":"Effects of grapefruit juice and orange juice on the intestinal efflux of P-glycoprotein substrates","volume":"19","author":"Tian","year":"2002","journal-title":"Pharm Res"},{"issue":"5","key":"10.1016\/j.xphs.2019.07.004_bib27","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.tiv.2015.04.011","article-title":"Rat precision-cut intestinal slices to study P-gp activity and the potency of its inhibitors ex\u00a0vivo","volume":"29","author":"Li","year":"2015","journal-title":"Toxicol In\u00a0Vitro"},{"issue":"5","key":"10.1016\/j.xphs.2019.07.004_bib28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/bdd.664","article-title":"Transport characteristics of candesartan in human intestinal Caco-2 cell line","volume":"30","author":"Zhou","year":"2009","journal-title":"Biopharm Drug Dispos"},{"issue":"12","key":"10.1016\/j.xphs.2019.07.004_bib29","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1007\/s11095-013-1063-y","article-title":"Improved oral bioavailability of BCS class 2 compounds by self nano-emulsifying drug delivery systems (SNEDDS): the underlying mechanisms for amiodarone and talinolol","volume":"30","author":"Elgart","year":"2013","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.xphs.2019.07.004_bib30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jconrel.2009.08.015","article-title":"Docetaxel microemulsion for enhanced oral bioavailability: preparation and in\u00a0vitro and in\u00a0vivo evaluation","volume":"140","author":"Yin","year":"2009","journal-title":"J\u00a0Control Release"},{"issue":"9","key":"10.1016\/j.xphs.2019.07.004_bib31","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1002\/jps.10176","article-title":"A\u00a0comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in\u00a0vitro","volume":"91","author":"Hugger","year":"2002","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2019.07.004_bib32","series-title":"Use of essential Oils to Increase Bioavailability of Orally Administered Pharmaceutical Compounds","author":"Benet","year":"2000"},{"issue":"6","key":"10.1016\/j.xphs.2019.07.004_bib33","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.addr.2007.09.010","article-title":"Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective","volume":"60","author":"Chen","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"issue":"21","key":"10.1016\/j.xphs.2019.07.004_bib34","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.drudis.2009.07.010","article-title":"Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation","volume":"14","author":"Bansal","year":"2009","journal-title":"Drug Discov Today"},{"issue":"1","key":"10.1016\/j.xphs.2019.07.004_bib35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijpharm.2008.05.015","article-title":"Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of protein drugs: III. In\u00a0vivo oral absorption study","volume":"362","author":"Rao","year":"2008","journal-title":"Int J Pharm"},{"issue":"Suppl 1","key":"10.1016\/j.xphs.2019.07.004_bib36","first-page":"51","article-title":"Endocytosis and exocytosis of nanoparticles in mammalian cells","volume":"9","author":"Oh","year":"2014","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.xphs.2019.07.004_bib37","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2017.09.019","article-title":"Cellular uptake of extracellular vesicles is mediated by clathrin-independent endocytosis and macropinocytosis","volume":"266","author":"Costa Verdera","year":"2017","journal-title":"J\u00a0Control Release"},{"issue":"2","key":"10.1016\/j.xphs.2019.07.004_bib38","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.nantod.2011.02.003","article-title":"Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies","volume":"6","author":"Iversen","year":"2011","journal-title":"Nano Today"},{"issue":"9","key":"10.1016\/j.xphs.2019.07.004_bib39","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1021\/mp400282r","article-title":"Enhanced oral delivery of paclitaxel using acetylcysteine functionalized chitosan-vitamin E succinate nanomicelles based on a mucus bioadhesion and penetration mechanism","volume":"10","author":"Lian","year":"2013","journal-title":"Mol Pharm"},{"issue":"10","key":"10.1016\/j.xphs.2019.07.004_bib40","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.2042-7158.1998.tb03319.x","article-title":"Biopharmaceutics: cytotoxicity of absorption enhancers in caco-2 cell monolayers","volume":"50","author":"Sakai","year":"1998","journal-title":"J\u00a0Pharm Pharmacol"},{"issue":"1","key":"10.1016\/j.xphs.2019.07.004_bib41","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0168-3659(02)00050-0","article-title":"Microemulsion formulation for enhanced absorption of poorly soluble drugs: II. In\u00a0vivo study","volume":"81","author":"Kawakami","year":"2002","journal-title":"J\u00a0Control Release"},{"issue":"3","key":"10.1016\/j.xphs.2019.07.004_bib42","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ejps.2012.07.005","article-title":"Evaluation of cytotoxicity of surfactants used in self-micro emulsifying drug delivery systems and their effects on paracellular transport in Caco-2 cell monolayer","volume":"47","author":"Ujhelyi","year":"2012","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2019.07.004_bib43","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ejps.2005.01.001","article-title":"Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells","volume":"24","author":"Sha","year":"2005","journal-title":"Eur J Pharm Sci"},{"issue":"10","key":"10.1016\/j.xphs.2019.07.004_bib44","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1023\/A:1018920728800","article-title":"Intestinal permeability enhancement: structure-activity and structure-toxicity relationships for nonylphenoxypolyoxyethylene surfactant permeability enhancers","volume":"11","author":"Swenson","year":"1994","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.xphs.2019.07.004_bib45","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijpharm.2006.02.053","article-title":"Synergistic absorption enhancement of salmon calcitonin and reversible mucosal injury by applying a mucolytic agent and a non-ionic surfactant","volume":"316","author":"Takatsuka","year":"2006","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2019.07.004_bib46","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jddst.2015.05.003","article-title":"Potential of a novel self nanoemulsifying carrier system to overcome P-glycoprotein mediated efflux of etoposide: in\u00a0vitro and ex\u00a0vivo investigations","volume":"28","author":"Akhtar","year":"2015","journal-title":"J\u00a0Drug Deliv Sci Technol"},{"issue":"8","key":"10.1016\/j.xphs.2019.07.004_bib47","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2217\/nnm-2016-0387","article-title":"Self-emulsifying preconcentrates of daidzein\u2013phospholipid complex: design, in\u00a0vitro and in\u00a0vivo appraisal","volume":"12","author":"Elnaggar","year":"2017","journal-title":"Nanomedicine"},{"issue":"2","key":"10.1016\/j.xphs.2019.07.004_bib48","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/1056-8719(94)00060-H","article-title":"Evaluation of mucosal damage of surfactants in rat jejunum and colon","volume":"33","author":"Oberle","year":"1995","journal-title":"J\u00a0Pharmacol Toxicol Methods"},{"issue":"8","key":"10.1016\/j.xphs.2019.07.004_bib49","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1023\/A:1018984731584","article-title":"Intestinal permeability enhancement: efficacy, acute local toxicity, and reversibility","volume":"11","author":"Swenson","year":"1994","journal-title":"Pharm Res"},{"issue":"5","key":"10.1016\/j.xphs.2019.07.004_bib50","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1021\/mp100149j","article-title":"Physiological parameters for oral delivery and in\u00a0vitro testing","volume":"7","author":"Mudie","year":"2010","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2019.07.004_bib51","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijpharm.2013.02.016","article-title":"Interactions between human multidrug resistance related protein (MRP2; ABCC2) and excipients commonly used in self-emulsifying drug delivery systems (SEDDS)","volume":"447","author":"Li","year":"2013","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2019.07.004_bib52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2165\/00003088-200241010-00002","article-title":"Clinical pharmacokinetics of candesartan","volume":"41","author":"Gleiter","year":"2002","journal-title":"Clin Pharmacokinet"},{"issue":"11","key":"10.1016\/j.xphs.2019.07.004_bib53","doi-asserted-by":"crossref","first-page":"13221","DOI":"10.3390\/molecules171113221","article-title":"Preparation of candesartan and atorvastatin nanoparticles by solvent evaporation","volume":"17","author":"Vaculikova","year":"2012","journal-title":"Molecules"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354919304393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354919304393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:27:50Z","timestamp":1758360470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354919304393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0022354919304393"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2019.07.004","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Self-Nanoemulsifying Drug Delivery System for Enhancing the Oral Bioavailability of Candesartan Cilexetil: Ex\u00a0Vivo and In\u00a0Vivo Evaluation","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2019.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}